Quick answer: to get semaglutide without insurance in 2026, the main legal route is buying brand-name Wegovy or Ozempic at Novo Nordisk’s self-pay prices: $149 to $299 a month for the pills and $199 to $499 a month for the pens, depending on dose.[1] That compares with a list price of $1,349.02 per package for Wegovy.[2] People with low incomes may qualify for free Ozempic through Novo Nordisk’s assistance program.[4]
Prices and program terms checked October 2026. They change often; confirm with the manufacturer or your plan.
Semaglutide is sold as Wegovy (pen and pill) for weight management, heart risk reduction and MASH, and as Ozempic (pen and pill) for type 2 diabetes.[11][12] Which one you can buy depends on what your prescriber writes, and a prescription is required for all of them.[1]
Self-pay prices through NovoCare Pharmacy
NovoCare Pharmacy is Novo Nordisk’s direct-to-patient pharmacy. Your prescriber sends the prescription, and the medicine ships to your home. Its published prices for people paying cash are:[1][3]
| Product and dose | Self-pay price per month |
|---|---|
| Wegovy pill 1.5 mg | $149 |
| Wegovy pill 4 mg | $199 |
| Wegovy pill 9 mg or 25 mg | $299 |
| Wegovy pen 0.25 mg or 0.5 mg, first two fills (new patients) | $199 |
| Wegovy pen 0.25 mg to 2.4 mg | $349 |
| Wegovy HD pen 7.2 mg | $399 |
| Ozempic pill 1.5 mg / 4 mg / 9 mg | $149 / $199 / $299 |
| Ozempic pen 0.25 mg or 0.5 mg, first two fills (new patients) | $199 |
| Ozempic pen 0.25 mg, 0.5 mg or 1 mg | $349 |
| Ozempic pen 2 mg | $499 |
The $199 new-patient pen price covers two monthly fills and must be filled by December 31, 2026.[1] A month means one box of four Wegovy pens, one Ozempic pen or one 30-tablet bottle.[1]
Two rules matter:
- Cash does not count toward insurance. Self-pay purchases cannot be submitted to an insurer and do not count toward your deductible or out-of-pocket limit.[2]
- Government coverage changes the rules. Ozempic’s terms say people enrolled in government programs cannot use the self-pay offer.[3] Check the current terms for your product before ordering.
For a side-by-side look at how the injection and pill compare, see our guide to semaglutide vs tirzepatide.
TrumpRx.gov
TrumpRx.gov, a federal website launched on February 5, 2026, points people to discounted manufacturer prices on branded drugs. The White House listed Ozempic and injectable Wegovy at an average of $350 and as low as $199 a month, and the Wegovy pill as low as $149, depending on dose.[5] These match the NovoCare self-pay prices above, so it is another way to reach the same offers rather than a lower price.
Patient assistance for low incomes
Novo Nordisk’s Patient Assistance Program (PAP) provides some medicines free to people who qualify:[4]
- Who can apply: people with no insurance, or with Medicare. People with private or commercial insurance are not eligible.
- Income limit for Ozempic: household income at or below 200% of the federal poverty level for uninsured applicants. Other covered medicines use a 400% limit.
- Medicare and Ozempic: Medicare enrollees with drug coverage can no longer get Ozempic through the PAP.
- Other programs first: you cannot qualify if you are eligible for Medicaid or Extra Help, and you may need a denial letter.
- Wegovy: the PAP page names Ozempic but does not mention Wegovy.
Uninsured patients are enrolled for 12 months. You can start an application online with your prescriber’s office or call 1-866-310-7549.[4] If you may qualify for Medicaid, read does Medicaid cover Ozempic first, and see how to get Wegovy for free for other no-cost routes.
What about the list price?
The list price is the starting price before discounts. NovoCare lists Wegovy at $1,349.02 per package and Ozempic pens at $1,027.51.[2][10] Novo Nordisk plans to lower the list price of Wegovy, Ozempic and Rybelsus to $675 a month on January 1, 2027, a cut of about 50% for Wegovy and 35% for Ozempic.[9]
That cut mainly helps people whose costs are tied to list price, such as those in high-deductible plans or paying coinsurance. Novo Nordisk says it does not change self-pay prices.[9]
Compounded semaglutide: what FDA allows now
During the semaglutide shortage, pharmacies were allowed to make compounded copies. That window has closed:
- February 21, 2025: FDA determined the semaglutide injection shortage was resolved.[6]
- Late April 2025: FDA’s grace period for state-licensed pharmacies and physicians (section 503A) ended.[6]
- May 22, 2025: the grace period for outsourcing facilities (section 503B) ended.[6]
- April 2026: FDA proposed excluding semaglutide, tirzepatide and liraglutide from the list of bulk substances outsourcing facilities may use, saying there is no clinical need for them to compound these drugs.[7]
Compounded drugs are not approved by FDA, meaning the agency has not reviewed them for safety, effectiveness or quality.[6] A 503A pharmacy may still compound semaglutide when a prescriber documents a significant difference for a specific patient, and FDA has said it does not intend to act when a pharmacy fills four or fewer prescriptions of an essentially-copy product in a month.[6] As of May 31, 2026, FDA had received 990 adverse event reports linked to compounded semaglutide, some involving possible dosing errors that led to hospitalization.[8] FDA also says salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from the approved drug, with no lawful basis it knows of for compounding them.[8]
Ways to lower your cash cost
- Ask about the pill. The Wegovy pill starts at $149 a month at the 1.5 mg dose, though your prescriber sets the dose and how fast it rises.[1]
- Use the new-patient pen price for your first two fills if you are starting injections before the end of 2026.[1]
- Check whether you actually lack coverage. Some plans cover Ozempic for type 2 diabetes or Wegovy for heart risk even when they exclude weight loss. See does insurance cover Wegovy.
- Re-check eligibility each year. Income-based programs and Medicaid rules change, and Medicare now has a $50-a-month route for some people (see does Medicare cover Ozempic).